Business
Publication of Poster by Mayo Clinic & US update
Publication of Poster by Mayo Clinic & US update.
About this update from Tristel Plc
[{"type":"text","content":"\n\nTRISTEL plc\n(\"Tristel\" or the \"Company\")\n \nPublication of Poster by Mayo Clinic\nNorth America update\n \nTristel plc (AIM: TSTL), the manufacturer of infection prevention products, notes the publication of a poster by the Mayo Clinic at the AORN* Global Surgical Conference & Expo in Boston, MA (USA) published this week, entitled, \"Implementing a new method of High-Level disinfection foam for ultrasound probes.\"\n \nThe poster reported on the outcome of a new method of High-Level Disinfection (\"HLD\"), Tristel ULT™, used in a 90-day trial by 11 Mayo Clinic staff members to reprocess 189 ultrasound probes, with no reported surgical site infections during the trial.\n \nThe poster described the new method of HLD foam as an effective and efficient method for HLD of ultrasound probes with minimal reprocessing turn-around time as well as being safe, easy to use, and cost effective. The poster also describes how the new HLD foam reduces reprocessing time minimising the number of ultrasound probes needed as well as reducing the damage to ultrasound probes compared to other methods.\n \nThe full poster can be viewed here: https://investors.tristel.com/wp-content/uploads/2025/04/AORN-Poster-Mayo-Clinic.pdf\n \nThis positive case-study of US adoption follows the news announced in February 2025 that an updated standard compiled by the Association for the Advancement of Medical Instrumentation (AAMI) and adopted by the American National Standards Institute (ANSI) acknowledged chlorine dioxide foam as a novel modality for high-level disinfection of medical devices.\n \nThis also adds to the growing number of US case studies that highlight Tristel ULT™ as a novel HLD able to achieve faster, simpler endocavitary probe processing for busy urology practices. In May 2024, US urologist, Dr Matthew Allaway, published a white paper called \"Simplifying High-Level Disinfection for Urological Procedures: A Case Study\" https://www.parkerlabs.com/wp-content/uploads/2024/04/AllawayWhitePaper_8_LOCKED.pdf\n \nNorth America update\nSales of Tristel ULT in North America continue to build momentum, with strong sequential growth delivered quarter on quarter in line with internal forecasts.\n \nThe solid growth reflects increasing adoption of the Company's technology, supported by growing customer...